---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026110"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T08:44:04.904964+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel removes ownership limit on Series A, B, C warrants, allowing full exercise of up to 654K shares

## Summary
- Amended warrants remove 4.99% Ownership Limitation on exercise and voting, effective September 1, 2025.
- Series A: 218K shares at $7.65; Series B: 218K at $9.00; Series C: 218K at $10.20, all expiring 5 years from issuance.
- Board and majority stockholder approved removal as disclosed in July 2025 Schedule 14C.
- No other terms of the warrants changed; cashless exercise provision remains in effect.

## SEC filing metadata
- accession: 0001641172-25-026110
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000164117225026110/0001641172-25-026110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000164117225026110/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026110
- JSON: https://secwatch.observer/filing/0001641172-25-026110.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.